Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Esophageal × gimeracil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 4 Pancreatic Neoplasms 2 Rectal Neoplasms 1 Malignant Neoplasms of Digestive Organs 1 Head and Neck Neoplasms 1 Fruquintinib 1 Esophageal Squamous Cell Carcinoma 1 Esophageal 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Biliary Tract Neoplasms 1 Apatinib Combined 1 Advanced Pancreatic Cancer 1

Interventions

nimotuzumab 1 gimeracil 1 endostar protein 1 Radiotherapy 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02749526 2022-07-29

Endostar Combined With MPFC Adjuvant Treatment of Esophageal Cancer Clinical Trial

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Terminated

Gastrointestinal

Esophageal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡